Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
about
The role of vascular endothelial growth factor a polymorphisms in breast cancerLarge-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk.Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population.Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.Genetic variations in VEGF and VEGFR2 and glioblastoma outcomeAssociation of VEGF and VDR gene- gene and gene- smoking interaction on risk of multiple myeloma in Chinese Han population.Discrepancies between VEGF -1154 G>A polymorphism analysis performed in peripheral blood samples and FFPE tissueAssociation of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis updateC936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinomaVascular endothelial growth factor (VEGF) -2578C/A and -460C/T gene polymorphisms and lung cancer risk: a meta-analysis involving 11 case-control studies.Association between the Functional Polymorphism of Vascular Endothelial Growth Factor Gene and Breast Cancer: A Meta-Analysis.Predictive value of vascular endothelial growth factor polymorphisms on the clinical outcome of renal cell carcinoma patients.Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patientsFour common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis.Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.Vascular endothelial growth factor polymorphisms as effect modifiers of oral squamous cell carcinoma risk: A systematic review and meta-analysisGenetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.Association of -2549 insertion/deletion polymorphism of vascular endothelial growth factor with breast cancer in North Indian patients.Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy.Patients' willingness to participate in a breast cancer biobank at screening mammogram.Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancerAssociation of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level.Vascular endothelial growth factor and hypoxia-inducible factor-1α gene polymorphisms and coronary collateral formation in patients with coronary chronic total occlusionsAngiogenesis-associated sequence variants relative to breast cancer recurrence and survival.Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesisAngiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.Association between vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 18 case-control studies.The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors.Prevalence of +405G>C,-1154G>A Vascular Endothelial Growth Factor Polymorphism in Breast Cancer.Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients.Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case-control studies.Vascular endothelial growth factor pathway.Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab.Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer.Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population.Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer.
P2860
Q26851522-8A7C8A24-EDE9-4E1F-8EB8-34846E58AA49Q33275297-4B29B926-C6E3-4B38-8D90-D12DD3253C6FQ33618522-259E1DF6-8F1B-492F-8839-5763DD1EF0C0Q33659635-B951AF0C-C0EA-4F2E-B6F7-7B50C32E9F6AQ33781960-EBEC80C0-EED8-49BE-A11F-4B004BDF6CBEQ33829546-EEE09037-52F8-42DA-B60C-0711C999037BQ34158325-21C2FDC3-E03B-4AC0-A1ED-64F37EFDDD7EQ34265586-1A2F2D9F-F3C5-4E67-AA85-175B22369BD1Q34469737-B5912B86-6FF5-437E-B6E6-61A528E37935Q34975344-068A0DB5-FC7B-4FA3-8852-7765B62827A3Q34990498-2A297C23-2B87-4216-AE83-6E3AB67A3C00Q34993717-2A359396-1742-4392-B140-1253AC6B19EDQ34996947-611A9F6D-B28C-4A3B-9C42-1827CB929A1FQ35009074-86E86CE1-DD6C-4CF9-980B-CA4A7E13829FQ35012794-16A808FE-51BA-40F4-A2CB-EB9CF853539DQ35179707-616A8C69-6CA9-4110-AE02-043E832305B2Q35912389-F4F8C5A2-1091-4A41-AF4C-6651453500A2Q36478084-7A4367CF-766E-4E99-A8B1-8584A81B0DCBQ36638595-26F598B2-EAB1-4B6D-844C-471FC624579AQ36691776-AAB8B934-C597-4846-B09B-6B5549CF3207Q36911942-E5F537BC-3311-4F90-A3CA-DE0997EAECE7Q37041198-845FB636-7EA8-4D5F-9C40-A3772439A928Q37121685-A947693A-5D76-4C44-8E3F-59AC3A85CDF0Q37187766-7BD6A149-B8FF-453C-87E1-0536B27175E2Q37197773-B0D561B5-8FF0-4200-B009-677CF8BE3FB0Q37221880-E8F6B5DD-545B-447A-9697-C97F47C0B085Q37304321-CDB7C096-4BDF-468E-81D3-45DCB7EC3AE7Q37310665-34876B8A-18C8-4A17-920D-B6979FB6777CQ37315498-27E6AD83-E7F8-4F84-B60D-50E660E88A86Q37348331-F9CFAF0B-B09D-468B-A4EA-D1A1A78DFFF9Q37362585-44C9F5D3-0E6F-4ABA-AA1B-EDF1E5DCDB58Q37521976-FDA84322-FC62-4A9C-B0A8-5C8ED912B25AQ37665244-BABBB82A-A81F-4796-A8A1-BA702D74CDE4Q37666428-4EC4B15C-B2FF-4B51-8D66-88AC9411C9BEQ37685955-9E106630-8C83-48A7-A7D6-D1088D8E1F8CQ37725978-2DCB7CA6-6AF3-4F64-93C8-6BF6B79641C9Q38307997-BBC28F77-EA84-4C4F-9F73-01EA7F6B0EE2Q38308001-30478C9D-D725-49CD-9021-F7399EC5F9F4Q38610074-E8563B7B-3943-44A3-B461-0B4248D18905Q39036253-7B388452-471A-4A25-BDD3-E3F74DAAC7CD
P2860
Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Vascular endothelial growth fa ...... cer development and prognosis.
@en
Vascular endothelial growth fa ...... cer development and prognosis.
@nl
type
label
Vascular endothelial growth fa ...... cer development and prognosis.
@en
Vascular endothelial growth fa ...... cer development and prognosis.
@nl
prefLabel
Vascular endothelial growth fa ...... cer development and prognosis.
@en
Vascular endothelial growth fa ...... cer development and prognosis.
@nl
P2093
P50
P1476
Vascular endothelial growth fa ...... cer development and prognosis.
@en
P2093
Beata Utracka-Hutka
Bowang Chen
Ewa Grzybowska
Helena Zientek
Jadwiga Rogozinska-Szczepka
Jolanta Pamula
Kerstin Enquist
Qianren Jin
Roger Henriksson
Rüdiger Klaes
P304
P356
10.1158/1078-0432.CCR-04-1803
P407
P577
2005-05-01T00:00:00Z